Nova Patents
IL231011B

Methods for reducing lipoprotein(a)levels by administering an inhibitor of proprotein convertase subtilisin kexin-9 (pcsk9)

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

55 members in 27 offices

This recordMember, by publication datePriority claim17 more offices are in the list below

Priority claims16

Priority claims
DocumentOfficeKindDate
201161535392United States of AmericaP
201161535392United States of AmericaP
201161559162United States of AmericaP
201161559162United States of AmericaP
201261641321United States of AmericaP
201261641321United States of AmericaP
2012054756United States of AmericaW
2012054756United States of AmericaW
61535392–––
61559162–––
61641321–––
PCTUS2012054756–––
US201161535392P–––
US201161559162P–––
US201261641321P–––
WO2012US54756–––

Members55

Family members, oldest first
DocumentOfficeKind
CA2848201A1CanadaA1
WO2013039969A1World Intellectual Property Organization (WIPO)A1
TW201329099ATaiwan Province of ChinaA
US2013243784A1United States of AmericaA1
AU2012308797A1AustraliaA1
CO6910163A2ColombiaA2
IL231011A0IsraelA0
IL231011D0IsraelD0
PH12014500342A1PhilippinesA1
AR087881A1ArgentinaA1
MX2014002158AMexicoA
KR20140075728ARepublic of KoreaA
SG2014010524ASingaporeA
EA201490641A1Eurasian Patent Organization (EAPO)A1
CN103930444AChinaA
EP2756004A1European Patent Office (EPO)A1
CL2014000605A1ChileA1
MA35430B1MoroccoB1
JP2014527967AJapanA
ZA201401114BSouth AfricaB
NZ621135ANew ZealandA
BR112014005522A2BrazilA2
AU2012308797B2AustraliaB2
JP6158813B2JapanB2
TWI601740BTaiwan Province of ChinaB
EA028278B1Eurasian Patent Organization (EAPO)B1
JP2017206520AJapanA
US10076571B2United States of AmericaB2
US2018333490A1United States of AmericaA1
MX363642BMexicoB
KR101964031B1Republic of KoreaB1
PH12014500342B1PhilippinesB1
MY170089AMalaysiaA
EP3536712A1European Patent Office (EPO)A1
EP2756004B1European Patent Office (EPO)B1
IL231011AIsraelA
IL231011BThis recordIsraelB
ES2773111T3SpainT3
CN103930444BChinaB
CN111789944AChinaA
CA2848201CCanadaC
US11116839B2United States of AmericaB2
EP3536712B1European Patent Office (EPO)B1
EP4252857A2European Patent Office (EPO)A2
ES2953713T3SpainT3
EP4252857A3European Patent Office (EPO)A3
EP4252857B1European Patent Office (EPO)B1
EP4252857C0European Patent Office (EPO)C0
EP4461373A2European Patent Office (EPO)A2
ES2992345T3SpainT3
HRP20241450T1CroatiaT1
EP4461373A3European Patent Office (EPO)A3
RS66342B1SerbiaB1
HUE069234T2HungaryT2
PL4252857T3PolandT3